Medistim ASA (0OCD) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medistim Asa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.045 Good morning everyone and welcome to the presentation of Medistim's 00:00:05.045 -- 00:00:10.300 third quarter results. So my name is Kari Krogstad and 00:00:10.300 -- 00:00:16.813 I have my CFO Thomas Jakobsen with me and we will take you through the results. 00:00:17.227 -- 00:00:21.634 Before entering into the highlights, I would like to remind ourselves 00:00:21.634 -- 00:00:26.702 on our track record and our commitment to deliver profitable growth consistently 00:00:26.702 -- 00:00:32.771 over time. And as these graphs are describing, that is, I promise we have delivered on. 00:00:32.771 -- 00:00:37.460 So let's look into the highlights for the third quarter. 00:00:37.460 -- 00:00:38.923 And 00:00:38.923 -- 00:00:43.032 after a record start of the year with the first half 00:00:43.032 -- 00:00:48.163 providing records both for sales and revenues, I'm very happy to present our best third 00:00:48.163 -- 00:00:53.991 quarter ever for both sales and revenues or operating profits. 00:00:54.065 -- 00:00:57.988 We can see that we are delivering 166.8 00:00:57.991 -- 00:01:01.157 million NOX in revenues. That's a 25.7% 00:01:01.157 -- 00:01:07.266 growth. And EBIT also growing very nicely, ending at 40.6 00:01:07.266 -- 00:01:09.607 million, 27.1% 00:01:09.831 -- 00:01:14.879 growth. We can see that we have very little currency effect this quarter. 00:01:14.879 -- 00:01:20.805 That means that the total sales is almost the same, 25.9%. 00:01:21.824 -- 00:01:26.274 And looking at the sales of our own products, 00:01:26.274 -- 00:01:31.507 we see that that is at almost 30 percent. So a very, very nice contribution 00:01:31.507 -- 00:01:36.479 from our own products this quarter. And Americas is continuing to take the lead here 00:01:36.4...